Accord Escalates Challenge Over Blood Pressure Patent
Accord has extended its challenge to Novartis' protections over its blood pressure medication, telling a London court that the original filing underpinning its patent was not inventive....To view the full article, register now.
Already a subscriber? Click here to view full article